AlphaCrest Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,021
| Closed | -$320K | – | 1428 |
|
|
2022
Q2 | $320K | Buy |
+10,021
| New | +$320K | 0.02% | 1098 |
|
|
2022
Q1 | – | Sell |
-9,131
| Closed | -$267K | – | 1460 |
|
|
2021
Q4 | $267K | Sell |
9,131
-7,914
| -46% | -$231K | 0.01% | 1284 |
|
|
2021
Q3 | $434K | Sell |
17,045
-7,963
| -32% | -$203K | 0.02% | 973 |
|
|
2021
Q2 | $876K | Buy |
+25,008
| New | +$876K | 0.04% | 728 |
|
|
2020
Q3 | – | Sell |
-4,400
| Closed | -$278K | – | 1221 |
|
|
2020
Q2 | $278K | Sell |
4,400
-3,100
| -41% | -$196K | 0.05% | 668 |
|
|
2020
Q1 | $383K | Buy |
+7,500
| New | +$383K | 0.05% | 692 |
|
|
2019
Q4 | – | Sell |
-5,700
| Closed | -$277K | – | 1425 |
|
|
2019
Q3 | $277K | Buy |
+5,700
| New | +$277K | 0.02% | 1120 |
|